Skip to main content

Table 1 Clinicopathologic features of patients with LUAD in the TCGA

From: An immune-related nomogram model that predicts the overall survival of patients with lung adenocarcinoma

Characteristic

Varl

Freq

Gender

Female

274 (53.73)

Male

236 (46.27)

Stage

Early

465 (91.18)

Late

37 (7.25)

NA

8 (1.57)

Smoke

NO

423 (82.94)

YES

87 (17.06)

Tstage

T1

167 (32.75)

T2

275 (53.92)

T3

46 (9.02)

T4

19 (3.73)

NA

3 (0.59)

Nstage

N0

1 (0.2)

N1

328 (64.31)

N2

96 (18.82)

N3

73 (14.31)

NX

2 (0.39)

Mstage

M0

361 (70.78)

M1

10 (1.96)

MX

5 (0.98)

NA

140 (27.45)

  1. Early means stage I/II and Late means stage III /IV, NA means no information available, NX and MX not evaluated N and M